Hepatitis C action plan for Scotland: phase II (May 2008 - March 2011)

David Goldberg, G. Brown, Sharon Hutchinson, J. Dillon, A. Taylor, G. Howie, S. Ahmed, Kirsty Roy, M. King

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)
51 Downloads (Pure)

Abstract

In 2004, the Scottish Government recognised that 'Hepatitis C is one of the most serious and significant public health risks of our generation' [1]. By December 2006, Health Protection Scotland (HPS) estimated that 50,000 people in Scotland had been infected with the hepatitis C virus (HCV) and that 38,000 were chronic carriers (Figure 1) [2]. Following an extensive consultation in 2005, the Health Minister and Chief Medical Officer launched Scotland's' Action Plan for Hepatitis C' in September 2006 [3]. Its aims are to prevent the spread of hepatitis C, particularly among intravenous drug users (IDUs), to diagnose hepatitis C-infected people, particularly those who would most benefit from treatment; and to ensure that those infected receive optimal treatment, care and support. The plan is a two-phased one. Phase I, undertaken during September 2006 to March 2008, involved increasing awareness about hepatitis C among professionals and gathering evidence through numerous surveys and other investigations to inform proposals for the development of hepatitis C services during Phase II (2008-2011)[4]. This paper presents the key findings of the evidence gathering exercise, recommended actions stemming from the evidence and funding associated with the actions.
Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalEurosurveillance
Volume13
Issue number4-6
Publication statusPublished - 22 May 2008

Keywords

  • hepatitis c
  • drugs
  • medical research
  • statistics
  • mathematics

Cite this